Introduction {#s1}
============

Normal developmental maturation of organ function requires precise transcriptional regulation of gene expression. This transcriptional regulation depends upon the interplay of an array of epigenetic regulators, which shape the epigenetic landscape by repositioning nucleosomes and depositing covalent modifications on histones. Since the chromatin landscape is established through a series of steps, each contingent upon normal completion of prior steps, transient disruption, through environmental mishaps or genetic mutations, might be anticipated to break the normal sequence and irreversibly impact organ development and function. Whether or not this is the case is presently unknown, and the answer has clear therapeutic implications for diseases that involve epigenetic changes.

Development and function of the heart is vulnerable to epigenetic insults, as mutation of epigenetic regulators causes both structural heart disease and cardiomyopathy in humans and in experimental model systems ([@bib20]; [@bib59]; [@bib16]; [@bib11]; [@bib34]; [@bib38]). Recent work has highlighted the critical role of epigenetic silencing of ectopic transcriptional programs in normal heart development and function ([@bib20]; [@bib11]; [@bib38]; [@bib53]). One class of epigenetic repressors are the histone deacetylases (HDACs), which remove activating histone acetylation marks to repress gene expression. HDACs consist of four classes (classes I, IIa, IIb, and IV) on the basis of their domain structure and expression pattern ([@bib31]; [@bib8]). Zhao and colleagues reported that HDACs target both actively transcribed and repressed genes to reset chromatin state for subsequent complex-dependent transcriptional outcome ([@bib55]). Consistent with this, class I HDACs such as HDAC1 and HDAC2 are frequently subunits of multi-protein complexes, such as Sin3, NuRD and CoREST. Inactivation of HDAC1/2 caused abnormal heart growth and function that was linked to ectopic expression of slow twitch skeletal muscle genes ([@bib38]). Class II HDACs were found to repress cardiac MEF2 transcription factor activity and their genetic inactivation caused pathological cardiac hypertrophy ([@bib60]).

Another class of epigenetic repressors is polycomb repressive complex 2 (PRC2), comprising the core subunits EED, SUZ12, and either EZH1 or EZH2. Canonically, PRC2 represses gene transcription by catalyzing trimethylation of histone H3 on lysine 27 (H3K27me3) ([@bib7]). However, whether or not H3K27me3 deposition is sufficient to account for PRC2-mediated transcriptional repression in all contexts remains uncertain. Margueron and colleagues reported that elevated EZH2 and H3K27me3 levels are a consequence of high proliferation of cells in tumorigenesis, arguing that perturbation of this equilibrium leads to irreversible transcriptional change ([@bib56]). In PRC2-null ESCs as well as other cell types, most genes that are marked by H3K27me3 remain repressed even after inactivation of PRC2 components, suggesting redundant repressive mechanisms. Furthermore, most studies of PRC2 function have been performed in actively cycling cells, whereas the majority of cells in adult mammals cycle slowly, and some cells, such as adult cardiomyocytes (CMs), are largely post-mitotic. Since cell cycle activity mandates re-deposition of histone marks ([@bib36]; [@bib17]), in mitotic cells writing activity of epigenetic complexes may overshadow other functions that are important in non-proliferating cells.

The role of PRC2 in the heart has been studied by cardiac-specific inactivation of EZH2 or EED during early cardiac development. This resulted in disruption of H3K27me3 deposition, derepression of non-cardiomyocyte gene programs, and lethal heart malformations ([@bib20]; [@bib11]). Here, we investigated the function of EED in postnatal heart maturation. Postnatal CMs have largely exited the cell cycle ([@bib4], [@bib5]; [@bib44]; [@bib2]; [@bib3]; [@bib48]; [@bib24]) and express little EZH2 protein ([@bib20]), but nonetheless contain abundant H3K27me3. Thus, the postnatal heart affords a unique opportunity to investigate the mechanism by which EED represses gene expression in post-mitotic cells and to harness this knowledge to determine whether the dysregulated chromatin landscape can be rewired to restore gene expression and heart function. We found that EED silences the slow-twitch myofiber gene program to orchestrate heart maturation by complexing with and stimulating HDAC deacetylase activity. Surprising, de-repression of the majority of genes in EED-deficient cardiomyocytes occurred without loss of H3K27me3, pointing to important EED repressive activity that is independent of its role in PRC2-mediated H3K27 trimethylation.

Results {#s2}
=======

Heart dysfunction in neonatal cardiac-inactivation of Eed {#s2-1}
---------------------------------------------------------

To understand the role of *Eed* in regulating cardiac gene expression during heart maturation, we generated *Eed*^fl/fl^; *Myh6*^Cre^ (Eed^CKO^) mice, in which *Myh6*^Cre^ specifically inactivates the conditional *Eed*^fl^ allele in CMs. Western blotting and qRTPCR demonstrated effective cardiac EED protein depletion that occurred between postnatal day (P) 0 and 5 ([Figure 1A](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). Eed^CKO^ mice were born at the expected Mendelian frequency, suggesting a lack of embryonic lethality, but most died over the first 3 months of life ([Figure 1B](#fig1){ref-type="fig"}). By echocardiography, Eed^CKO^ mice had left ventricular dilatation and progressive systolic dysfunction ([Figure 1C](#fig1){ref-type="fig"} and [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"}). Histopathological examination confirmed massive cardiomegaly ([Figure 1D--F](#fig1){ref-type="fig"}). The expression level of the heart failure marker *Nppa,* encoding atrial natriuretic factor, was strongly upregulated ([Figure 1---figure supplement 2B](#fig1s2){ref-type="fig"}). Eed^CKO^ mice that survived to 2 months of age had substantial CM hypertrophy and cardiac fibrosis ([Figure 1---figure supplement 2C--F](#fig1s2){ref-type="fig"}). These results show that *Eed* is essential for neonatal heart maturation and that its inactivation in CMs causes lethal dilated cardiomyopathy.10.7554/eLife.24570.002Figure 1.Neonatal cardiomyocyte inactivation of *Eed* caused lethal dilated cardiomyopathy.(**A**) EED protein expression in WT and cardiac Eed^CKO^ (CKO, Myh6-Cre^+^;Eed^f/f^) on postnatal days 0 (P0) and 5 (P5). Quantification shows relative EED protein normalized to GAPDH loading control. Several splice isoforms of EED were detected. \* indicates a non-specific band that is larger than full length EED\'s predicted molecular weight. (**B**) Kaplan-Meier survival curve of WT and Eed^CKO^ mice. (**C**) Heart function was measured by echocardiography as fractional shortening (FS%) at 2 months of age. See [Figure 1---figure supplement 2A](#fig1s2){ref-type="fig"} for FS% at earlier time points. (**D--F**) Cardiac dilatation and hypertrophy were observed by heart to body weight ratio (**D**), gross morphology (**E**), and histology (**F**) in WT and Eed^CKO^ at 2 months of age. Representative hearts are shown. Bar = 1 mm. (**G**) Immunoblotting for H3K27me3 in cardiomyocytes from WT and Eed^CKO^ at 2 months of age. (**H**) Genome-wide distribution of H3K27me3 ChIP-seq signals in WT and Eed^CKO^ purified cardiomyocytes. ChIP-seq signal was measured in 1 kb windows across the genome. The signal distribution is displayed as a violin plot. Yellow lines denote the median value. (**I**) Venn diagram showing the distribution of H3K27me3 peaks in WT and Eed^CKO^ heart. (**J**) Heat map of RNA transcript levels of differentially expressed genes (fold-change \>1.5 or \<0.67 and adjusted p-value\<0.05) are shown in the left heatmap. Expression values for each gene were row scaled. Selected contractile myofiber and heart failure marker genes are shown in red and black, respectively. Right heatmap shows H3K27me3 and EED ChIP-seq signal at the transcriptional start site (TSS) of the differentially expressed gene on the same row. Gene expression, H3K27me3, and EED ChIP-seq studies were performed on purified cardiomyocytes at 2 months of age. Rows were ordered by k-means clustering on H3K27me3 and EED ChIP-seq signal into three clusters, C1-C3. (**K**) Gene Ontology analysis of differentially expressed genes between WT and Eed^CKO^. The top six significant terms are shown. (**L**) Box plots showing H3K27me3 signals in these three clusters as shown in J. A, C, D, Student's t-test; H, L, Wilcoxon-Mann-Whitney test. \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001, NS, not significant. Numbers in bars indicate independent biological replicates.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.002](10.7554/eLife.24570.002)10.7554/eLife.24570.003Figure 1---figure supplement 1.Eed depletion in WT and EedCKO mice.Heart apexes were harvested for qRT-qPCR for relative Eed mRNA expression on postnatal days 0 (P0) and 5 (P5). Heart apex contains both cardiomyocytes and non-cardiomyocytes. The non-myocytes likely account for the detected level of Eed mRNA in EED-CKO. p-Value by Student's t-test. \*\*\*p\<0.001. NS, not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.003](10.7554/eLife.24570.003)10.7554/eLife.24570.004Figure 1---figure supplement 2.Characterization of EedCKO mice.(**A**) Progressive cardiac dysfunction and dilatation after cardiomyocyte-restricted ablation of Eed. w, weeks. (**B**) Nppa mRNA level in WT and CKO hearts at the indicated ages. w, weeks. (**C, D**) Cardiac fibrosis was evident by Mason Trichrome staining at 2 months of age. Fraction of myocardial area occupied by fibrotic tissue (blue staining) was quantified using ImageJ. Bar = 50 µm. (**E, F**) Immunofluorescence for cardiomyocyte marker TNNI3 and cardiomyocyte membrane marker WGA, and quantification of cell size from WGA-stained cardiomyocyte outlines (f). Bar = 50 µm. (G) Immunostaining for TNNI3 and H3K27me3. Isolated adult cardiomyocytes were \>95% pure and EedCKO CMs had little H3K27me3 signal. Bar = 50 µm. (H) PCR of genomic DNA from purified CMs using primers that amplify unexcised floxed DNA (233 bp product) or Cre-excised DNA (453 bp product). In CKO-purified CMs, unexcised floxed DNA was not detected, consistent with highly efficient Cre-mediated gene inactivation, as well as high purity of dissociated CMs. (I) RNA-seq track view showing deletion of floxed exons 3--6 of Eed (red box). (**J,K**) Genome browser view ofH3K27me3 and H3K27ac ChIP-seq signals on Myh6 (**J**) and Vim (**K**) loci in purified adult cardiomyocytes. (**L**) EED enrichment on downstream genes was measured by ChIP-qPCR in P5 heart ventricle apex. Numbers following gene names indicate the number of nucleotides between the probed amplicon and the TSS. (**M**) Box and scatter plots of H3K27me3 at TSS ±500 bp of EED target genes in four quantiles of WT H3K27me3 intensity. (**N**) Aggregation plots of H3K27me3 ChIP-seq signals near the TSS of genes upregulated, downregulated, or unchanged between WT and EEDCKO. O. H3K27me3 enrichment was measured by ChIP-qPCR on target genes using adult cardiomyocytes isolated from WT and EEDCKO hearts. \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001 by ANOVA with Dunnett's post-hoc test using Eedfl/+::Myh6-Cre-- as the control group (A), by Welch's t-test (B,D,F,N,O), or by Wilcoxon-Mann-Whitney test (**M**).**DOI:** [http://dx.doi.org/10.7554/eLife.24570.004](10.7554/eLife.24570.004)

Global distribution of H3K27me3 on the promoters/enhancers of derepressed genes {#s2-2}
-------------------------------------------------------------------------------

EED is a central, non-redundant subunit of PRC2, an enzyme that canonically represses its target genes by depositing repressive H3K27me3 epigenetic marks ([@bib36]; [@bib17]). As expected, cardiac *Eed* inactivation globally decreased H3K27me3 level in CMs ([Figure 1G](#fig1){ref-type="fig"}). Genome-wide H3K27me3 occupancy also showed the anticipated global reduction of H3K27me3 signal ([Figure 1H](#fig1){ref-type="fig"}). Accordingly, *Eed* inactivation reduced the number of regions enriched for H3K27me3 across the genome from 49991 to 7095 ([Figure 1I](#fig1){ref-type="fig"} and [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). Of the 7095 H3K27me3-occupied regions in Eed^CKO^ CMs, 5009 were also observed in wild-type CMs and 2086 were not ([Figure 1I](#fig1){ref-type="fig"}). These 2086 new peaks had low intensity, and their centers were distributed as follows: 1040 (49.86%) in intergenic regions, 192 (9.20%) in promoter regions, 721 (34.56%) in introns, 98 (4.70%) in exons, and 35 (1.68%) in 5\' and 3\' UTR.

To gain insights into the mechanisms underlying the dilated cardiomyopathy phenotype, we performed gene expression profiling of dissociated, purified, 8-week-old CMs using RNA-seq. We identified 863 upregulated and 392 downregulated genes in Eed^CKO^ (fold change \>1.5 or \<0.67 and adjusted p-value\<0.05; [Figure 1J](#fig1){ref-type="fig"} and [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). Remarkably, we found that slow-twitch myofiber genes, such as *Tnnt1*, *Tnni1*, *Myh7*, *Mybpc1*, *Myl9*, *Myl7*, *Myl4*, *Mybpc2,* and *Acta1*, were significantly upregulated in Eed^CKO^ heart ([Figure 1J](#fig1){ref-type="fig"}). Indeed, the upregulated genes were significantly enriched for gene ontology terms related to skeletal muscle genes ([Figure 1K](#fig1){ref-type="fig"}). Normal cardiac function requires proper expression of cardiac sarcomere genes and repression of skeletal muscle and slow-twitch myofiber genes ([@bib15]; [@bib38]; [@bib12]), suggesting that abnormal expression of these genes contributes to weak cardiac contraction in Eed^CKO^ mice.

To dissect the relationship between the differentially expressed genes and H3K27me3, H3K27ac, and EED occupancy, we performed chromatin immunoprecipitation followed by high-throughput sequencing (ChIP-seq) in purified, 2-month-old CMs. CMs were over 95% pure by immunofluorescence microscopy ([Figure 1---figure supplement 2G](#fig1s2){ref-type="fig"}). Markedly reduced H3K27me3 in Eed^CKO^ CMs demonstrated highly efficient EED inactivation ([Figure 1---figure supplement 2G](#fig1s2){ref-type="fig"}). PCR of genomic DNA from purified CMs, as well as review of the RNA-seq track view of the *Eed* locus, further indicated both efficient gene inactivation by Myh6-Cre, which is CM-specific, as well as high CM purity ([Figure 1---figure supplement 2H,I](#fig1s2){ref-type="fig"}). ChIP-seq signals were consistent high CM purity. For example, at *Myh*6, expressed in CMs, showed robust signal for the active mark H3K27ac and little signal from the repressive mark H3K27me3 ([Figure 1---figure supplement 2J](#fig1s2){ref-type="fig"}). On the other hand, *Vim*, expressed in non-CMs, lacked H3K27ac and was enriched for H3K27me3 ([Figure 1---figure supplement 2K](#fig1s2){ref-type="fig"}).

About half of the upregulated genes (49.71%), including 7 of 14 upregulated skeletal muscle genes, were occupied by EED at their TSSs in WT. EED occupancy at a subset of the upregulated genes was confirmed by ChIP-qPCR ([Figure 1---figure supplement 2L](#fig1s2){ref-type="fig"}). Unlike upregulated genes, only 8.42% of downregulated genes were bound by EED and H3K27me3. These findings suggest that gene upregulation (derepression) rather than downregulation is the predominant, direct effect of EED deficiency, and that repression of skeletal muscle genes is a key direct role of EED in adult heart.

We evaluated the relationship between H3K27me3 occupancy and gene upregulation in Eed^CKO^. First, we quantitatively measured H3K27me3 signal within ±500 bp of TSS on EED target genes in control and Eed^CKO^, stratified by H3K27me3 signal in wild type ([Figure 1---figure supplement 2M](#fig1s2){ref-type="fig"}). This analysis showed that EED inactivation reduced the median H3K27me3 signal only of the quartile of genes with highest H3K27me3 occupancy in wild type. Surprisingly, the median H3K27me3 signal in the remaining three quartiles of upregulated genes was not significantly altered by EED inactivation. Consistent with this analysis, the aggregate H3K27me3 signal at the promoters of the 863 upregulated genes was not reduced in Eed^CKO^, while it was lower in Eed^CKO^ at the unchanged and downregulated genes ([Figure 1---figure supplement 2N](#fig1s2){ref-type="fig"}). To further corroborate these findings, we divided upregulated genes into three clusters ([Figure 1J](#fig1){ref-type="fig"}): those in which upregulation was coupled to H3K27me3 reduction (Cluster C1), those with low H3K27me3 signal (C2), and those with no change in H3K27me3 signal (C3). Cluster C1, which matches the canonical view in which gene derepressed is association with loss of H3K27me3 ([@bib36]; [@bib17]; [@bib6]), contained only 252 of 863 upregulated genes (29%) in Eed^CKO^. In comparison, 4731 of 10,024 expressed genes (47%) had reduced promoter H3K27me3, indicating lack of enrichment of H3K27me3 loss among upregulated genes. Again, the expected relationship between gene upregulation and H3K27me3 loss did not hold for the majority of upregulated genes, as those in Clusters 2 (303 genes) and 3 (308 genes) were not linked to loss of H3K27me3 ([Figure 1L](#fig1){ref-type="fig"}). Togerther, these analyses indicate that the majority of gene upregulation that occurs with Eed inactivation occurs without loss of H3K27me3. These conclusions were robust to the normalization method used for H3K27me3 ChIP-seq analysis (see Materials and methods), indicating that it was not a result of global differences in H3K27me3 between WT and Eed^CKO^. Furthermore, we independently confirmed retention of H3K27me3 at promoters of selected upregulated genes by ChIP-qPCR ([Figure 1---figure supplement 2O](#fig1s2){ref-type="fig"}).

Overall, these results indicate that upregulation of most genes in Eed^CKO^, including the derepressed skeletal muscle genes, was not accompanied by loss of H3K27me3, as expected by the canonical model of EED repression via 'writing' of repressive H3K27me3 marks ([@bib36]; [@bib17]).

Elevated H3K27ac at genes upregulated in Eed^CKO^ {#s2-3}
-------------------------------------------------

Our data suggested that EED repressed gene expression in the postnatal heart through mechanisms other than H3K27me3 deposition. Acetylation of H3K27 (H3K27ac) is linked to gene activation and active enhancers ([@bib18]; [@bib42]; [@bib14]). Increased H3K27ac was previously noted in embryonic stem cells with PRC2 loss of function ([@bib14]; [@bib40]). Immunoblotting of purified Eed^CKO^ CMs showed that *Eed* inactivation markedly increased total histone H4 acetylation and acetylation of histone H3 at K9 and K27 ([Figure 2A](#fig2){ref-type="fig"}); H3K14ac showed a trend toward being higher in Eed^CKO^, although the difference was not statistically significant (p=0.074; [Figure 2A](#fig2){ref-type="fig"}). This result was unlikely to be an indirect result of cardiac dysfunction in Eed^CKO^ hearts, because a similar effect was observed after acute, siRNA-mediated *Eed* knockdown in the HL-1 CM-like cell line ([Figure 2B](#fig2){ref-type="fig"}).10.7554/eLife.24570.005Figure 2.*Eed* depletion induced globally elevated histone acetylation.(**A**) Global upregulation of histone H3 and H4 acetylation at different lysine residues in isolated adult cardiomyocytes from 2-month-old WT and Eed^CKO^ hearts. Histone levels were measured by immunoblotting and further quantified by normalization to total histone H3. (**B**) Acute EED depletion increased H3K27ac levels in HL-1 cardiomyocyte-like cells. Fully confluent HL-1 cells were transfected with TriFECTa DsiRNAs against Eed (si-Eed) or scrambled sequence-negative control (si-NC). Protein levels were measured by quantitative immunoblotting. Arrow, EED band. Asterisk, non-specific band. (**C**) Venn diagram showing the overlap of H3K27ac ChIP-seq peaks in isolated cardiomyocytes from WT and Eed^CKO^ hearts at 2 months of age. (**D**) Genome-wide distribution of H3K27ac signals. The violin plot displays H3K27ac ChIP-seq signals in 1 kb windows across the genome. Yellow horizontal lines denote median values. (**E**) Aggregation plots of H3K27ac ChIP-seq signals at ±5 kb of TSS (upper row) or at distal regions (lower row) of genes that were upregulated, downregulated, or unchanged by *Eed* inactivation. (**F--G**) Heat map (**F**) and box plots (**G**) of H3K27ac levels at TSS of differentially expressed genes. The row order and clustering is the same as in [Figure 1J](#fig1){ref-type="fig"}. A, B, Unpaired Student's t-test; D,G, Wilcoxon-Mann-Whitney test. \*\*p\<0.01; \*\*\*p\<0.001; NS, not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.005](10.7554/eLife.24570.005)10.7554/eLife.24570.006Figure 2---figure supplement 1.H3K27ac ChIP-qPCR validation.H3K27ac enrichment was measured by ChIP-qPCR on target genes using adult cardiomyocytes isolated from WT and EEDCKO hearts. \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001 by Welch's t-test.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.006](10.7554/eLife.24570.006)

Genome-wide H3K27ac occupancy analysis by ChIP-seq in 2-month-old WT or Eed^CKO^ purified CMs showed that *Eed* inactivation led to acquisition of 8161 new H3K27ac sites and loss of 5950 sites, with 20799 sites in common ([Figure 2C](#fig2){ref-type="fig"} and [Supplementary file 1](#SD1-data){ref-type="supplementary-material"}). These peak changes were accompanied by a broad, genome-wide increase of H3K27ac signal strength ([Figure 2D](#fig2){ref-type="fig"}). Indeed, the aggregate H3K27ac signal at the promoters of the 863 genes upregulated in Eed^CKO^ increased, whereas it was either unchanged or reduced for the genes that were unchanged or downregulated, respectively ([Figure 2E](#fig2){ref-type="fig"}). These results were validated by ChIP-qPCR at the promoters of several slow twitch muscle genes that were upregulated in Eed^CKO^ ([Figure 2---figure supplement 1](#fig2s1){ref-type="fig"}). Increased H3K27ac signal was also observed at enhancer regions (H3K27ac peaks region in either WT or Eed^CKO^) associated with these upregulated genes ([Figure 2E](#fig2){ref-type="fig"}). Next, we further examined the specific TSS regions for the correlation of H3K27ac change with gene upregulation ([Figure 2F](#fig2){ref-type="fig"}; rows ordered as in [Figure 1J](#fig1){ref-type="fig"}). Heatmap analysis of all three clusters and quantitative analysis in box plots for each cluster confirmed that all 863 derepressed genes markedly gained H3K27ac levels ([Figure 2F,G](#fig2){ref-type="fig"}). Together these data suggest that EED is required to suppress H3K27ac, and that loss of this function leads to abnormal H3K27ac accumulation, global increase in histone H3 and H4 acetylation, and aberrant gene upregulation.

Reintroduction of EED normalizes heart function and reinstates H3K27ac but not H3K27me3 {#s2-4}
---------------------------------------------------------------------------------------

Additional data from timed EED replacement studies further strengthened the relationship between the Eed^CKO^ phenotype and H3K27ac rather than H3K27me3. EED has been proposed to facilitate perpetuation of H3K27me3 marks by itself binding to H3K27me3, thereby reinforcing deposition of H3K27me3 at existing sites ([@bib36]; [@bib17]). If this is the case, then ablation of EED should disrupt the H3K27me3 landscape, preventing its restoration even if EED is later re-expressed. To test this model, we temporally re-expressed EED in CMs by taking advantage of highly efficient, durable, and CM-selective gene transfer using adeno-associated virus serotype 9 (AAV9) and the cardiac troponin T promoter (*Tnnt2*) ([@bib35]; [@bib26]). We developed AAV9-Tnnt2-EED (abbreviated AAV9-EED) and validated that it drove cardiac expression of EED when delivered to mice at P14 or P25 ([Figure 3---figure supplement 1A--C](#fig3s1){ref-type="fig"}). We evaluated the effect of delayed EED re-expression at either P14 or P25 ([Figure 3A](#fig3){ref-type="fig"}). Interestingly, delayed EED re-expression was still able to rescue cardiac systolic function and cardiac hypertrophy, normalize expression of myofiber and heart failure genes, and ameliorate cardiomegaly of Eed^CKO^ mutants ([Figure 3B--D](#fig3){ref-type="fig"} and [Figure 3---figure supplement 1D](#fig3s1){ref-type="fig"}).10.7554/eLife.24570.007Figure 3.Delayed re-expression of EED rescued heart function and normalized H3K27ac but not H3K27me3.(**A**) Schematic of the experimental design. AAV9 expressing EED or luciferase (luc) in cardiomyocytes was injected at P14, or P25 to control or Eed^CKO^ mice. Lines represent the temporal pattern of EED expression. (**B--E**) Heterozygous (Het; Eed^fl/+^; Myh6Cre^+^) and Eed^CKO^ mice were injected with AAV-luc or AAV-EED at indicated ages. At 2 months of age, heart function (FS%) was measured by echocardiography (**B**), and expression of *Myh7* and *Acta1*, two slow-twitch myofiber genes aberrantly expressed in Eed^CKO^, were measured by qRTPCR (**C**). Representative images showing gross morphology of hearts at 2 months of age (**D**). Cardiomegaly of CKO-luc hearts was abrogated by EED replacement at P14 or P25. Isolated cardiomyocytes were immunoblotted to measure expression of virally delivered EED, and global levels of H3K27ac and H3K27me3 (**E**) Graphs show quantitation of global H3K27ac and H3K27me3 levels, normalized to histone H3. (**F**) Heatmaps of RNA expression, H3K27me3 and H3K27ac ChIP signals at ±5 kb of TSS of 863 upregulated genes from Eed^CKO^ mice injected with AAV-luc or AAV-EED at P14 or P25. Row order and cluster labels are the same as [Figure 1J](#fig1){ref-type="fig"}. (**G**) Quantitative analysis of H3K27me3 and H3K27ac ChIP signals near TSSs shown in F by box plots. (**H**) Genome browser view of H3K27me3 and H3K27ac ChIP-seq signals at the *Acta1* or *Myl7* loci. The regions highlighted in gray show that gain of H3K27ac in Eed^CKO^ was reset to normal under EED rescue conditions regardless of H3K27me3 status. B, C, and E, Unpaired Student's t-test; G, Wilcoxon-Mann-Whitney test. \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.007](10.7554/eLife.24570.007)10.7554/eLife.24570.008Figure 3---figure supplement 1.AAV9-EED rescue of EEDCKO mice.(**A**) Schematic of AAV9 constructs expressing Flag-tagged EED (Flag-EED), GFP or luciferase. ITR, Inverted Terminal Repeart. PTnnt2, cardiac-specific troponin T promoter. (**B**) AAV9-EED expression of Flag-EED. Mice were treated with AAV9-EED at P5 or P25. Heart extracts were prepared at 2 months of age. WT, untreated wild-type mice. (**C**) Brightfield and GFP fluorescent signals in hearts of mice injected with AAV9-GFP at P5 or P25 and harvested at 2 months of age. Bar = 500 µm. (**D**) qRTPCR was performed to validate the expression of the indicated genes in cardiomyocytes from 2-month-old mice treated with AAV9-luc or AAV9-EED at P14 and P25.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.008](10.7554/eLife.24570.008)

Next, we investigated the effect of delayed EED re-expression on the chromatin landscape. Delayed EED re-expression corrected the abnormally high global H3K27ac levels observed in Eed^CKO^ ([Figure 3E](#fig3){ref-type="fig"}). However, delayed EED re-expression did not correct the low H3K27me3 levels seen in Eed^CKO^ ([Figure 3E](#fig3){ref-type="fig"}). This result was reinforced by genome-wide measurement of H3K27me3 and H3K27ac chromatin occupancy by ChIP-seq. Whereas EED re-expression at P14 and P25 both conferred phenotypic rescue and normalized the genome-wide distribution of H3K27ac signal, P14 and P25 EED re-expression did not normalize H3K27me3 distribution ([Figure 3F,G](#fig3){ref-type="fig"}).

We then evaluated the effect of EED re-expression on the 863 genes derepressed in CKO-luc by performing RNA-seq on purified CMs. Out of 863 genes that were upregulated in Eed^CKO^, 256 (66, 87, and 103 in Cluster 1, 2, and 3, respectively) were significantly downregulated ([Figure 3F](#fig3){ref-type="fig"}). This normalization of gene expression was associated with reduction of H3K27ac, but not H3K27me3, near the TSS ([Figure 3F,G](#fig3){ref-type="fig"}). Inspection of the *Acta1* and *Myl7* loci reinforced the finding that, at the upregulated slow twitch skeletal muscle genes, delayed EED re-expression corrected abnormal deposition of H3K27ac but did not significantly affect H3K27me3 ([Figure 3H](#fig3){ref-type="fig"}). These data are consistent with the model that EED 'reads' its own mark to reinforce its 'writing', so that proper writing cannot be restored after a period has elapsed during which the mark decays. An alternative explanation is that CM PRC2 histone trimethylase activity declines with age due to downregulation of EZH2 and lack of detectable trimethylase activity from EZH1-containing complexes from adult CMs. Regardless of the precise mechanism, our data show that phenotypic rescue and gene expression correction by AAV-EED were not associated with normalization of H3K27me3. Rather, correction aligned with normalization of H3K27ac epigenetic marks.

EED interacts with HDACs and enhances its deacetylase activity but is dispensable for HDAC recruitment {#s2-5}
------------------------------------------------------------------------------------------------------

Histone H3 and H4 acetylation, including H3K27ac, is regulated by a balance between histone acetyltransferases and histone deacetylases (HDACs) ([@bib49]; [@bib50]; [@bib55]). HDACs generally function as co-repressors, and class I and class II HDACs have critical roles in regulating cardiac gene expression and function, including suppression of skeletal muscle gene expression ([@bib38]; [@bib47]; [@bib60]; [@bib52]). Although Eed^CKO^ hearts had elevated global histone H3 and H4 acetylation, most strikingly inducing H3K27ac, total HDAC levels were not changed ([Figure 4---figure supplement 1A,B](#fig4s1){ref-type="fig"}). Otte and colleagues showed that HDAC2 interacts with EED and that EED co-immunoprecipitated protein complexes containing HDAC activity ([@bib54]), suggesting that HDACs participate in EED-mediated gene repression. These lines of evidence led us to hypothesize that EED represses its postnatal cardiac target genes by interacting with HDACs to decrease their H3K27ac. To test this hypothesis, we screened class I and class II HDACs (HDAC1-HDAC9) for interaction with EED. Immunoprecipitation of FLAG-tagged HDAC1-HDAC9 co-precipitated HA-tagged EED, with the exception of HDAC8 ([Figure 4A](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1C](#fig4s1){ref-type="fig"}). This was confirmed by reciprocal immunoprecipitation experiments, in which HA-EED co-precipitated HDAC1-HDAC9 except HDAC8 ([Figure 4A](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1D](#fig4s1){ref-type="fig"}). We further confirmed the interaction of endogenous EED and HDAC2 in HL-1 CM-like cells ([Figure 4B](#fig4){ref-type="fig"}).10.7554/eLife.24570.009Figure 4.EED interacts with and co-localizes with HDAC to repress transcription through enhancing its deacetylation activity.(**A**) Co-Immnoprecipitation analysis of EED-HDAC interaction in 293 T cells. HA-EED pull down with HA antibody co-precipitated FLAG-HDAC1/2/3 (left). Reciprocally, FLAG-HDAC1/2/3 pull down with Flag antibody co-precipitated HA-EED (right). Data on HA-EED and Flag-HDAC4-9 interaction are presented in [Figure 4---figure supplement 1C,D](#fig4s1){ref-type="fig"}. (**B**) Interaction between endogenous EED and HDAC2. EED, immunoprecipitated from HL-1 cardiomyocyte-like cells, co-precipitated HDAC2. Arrowhead denotes the specific band and asterisk denotes the non-specific IgG heavy chain band. (**C**) Venn diagram showing overlap of EED and HDAC2 peaks in WT. (**D**) Heatmaps showing ChIP-seq signals for EED, H3K27me3, H3K27ac and HDAC2 at ±5 kb of EED peak centers. Rows were sorted by ascending EED peak signal. (**E**) Aggregate plot showing HDAC2 ChIP signals in WT and Eed^CKO^, centered on EED peak centers. (**F**) HDAC2 occupancy of the indicated chromatin regions in isolated cardiomyocytes from WT and Eed^CKO^ mice at 2 months of age. Occupancy was measured by ChIP followed by quantative PCR (ChIP-qPCR). Chromatin regions are named by the adjacent gene and the distance to the TSS. (**G**) Aggregation plot showing HDAC2 ChIP-seq signals in WT and Eed^CKO^ at ±5 kb of TSS of genes that were upregulated, unchanged or downregulated in Eed^CKO^. (**H**) Effect of EED on HDAC2 activity. In vitro deacetylation assay was performed using recombinant active HDAC2 (50 ng) in the presence of BSA or 5 to 100 ng of recombinant EED, purified from insect cells. Deacetylation activity was measured by colorimetric assay. F, H, I, J, K, Unpaired Student's t-test. \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.009](10.7554/eLife.24570.009)10.7554/eLife.24570.010Figure 4---figure supplement 1.HDAC-EED interaction.(**A**) RNA-seq data showing that HDAC transcript levels did not change in 2-month-old EedCKO cardiomyocytes. DE, Differential Expression; NS, not significant. (**B**) Immunoblotting for HDAC1, 2, and 5 proteins in adult cardiomyocytes isolated from hearts of control (WT) and EedCKO (CKO). (**C**) HA-EED, pulled down with HA antibody, co-immunoprecipitated HDAC4/5/6/7/9. HA-EED and HDAC4-9 were co-transfected into 293T cells and harvested for immunoprecipitation assay 48 hr after transfection. Arrowheads indicate full-length HDAC proteins. (**D**) Flag-HDAC4/5/6/7/9, pulled down with Flag antibody, co-immunoprecipitated HA-EED. Arrowheads indicate full-length HDAC proteins. (**E**) HDAC5 occupancy measurement by ChIP-qPCR. HDAC5 occupancy of the indicated chromatin regions in isolated adult CMs from WT and EedCKO mice at 2 months of age. Occupancy was measured by ChIP followed by quantative PCR (ChIP-qPCR). Chromatin regions are named by the adjacent gene and the distance to the transcriptional start site (TSS).**DOI:** [http://dx.doi.org/10.7554/eLife.24570.010](10.7554/eLife.24570.010)10.7554/eLife.24570.011Figure 4---figure supplement 2.Validation of HDAC2 and EED proteins purity and dCas9-EED interaction with EZH2.Coommassie brilliant blue staining of recombinant purified HDAC2 and EED proteins. The lot \# specific staining gel image was proided by the manufacturer, Cayman Chemical.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.011](10.7554/eLife.24570.011)

To further approach the molecular function of this interaction on a genome-wide level, we examined the genomic binding distribution of EED and HDAC2 in adult CMs. Nearly half of HDAC2 peaks (4042 out of 9869, 41%) overlapped with EED peaks in WT, in line with their biochemical interaction ([Figure 4C](#fig4){ref-type="fig"}). HDAC2, H3K27me3, and H3K27ac signal at the entire set of 8625 EED occupied regions further confirmed this result ([Figure 4D](#fig4){ref-type="fig"}). We identified three classes of EED-bound genomic domains ([Figure 4D](#fig4){ref-type="fig"}). A first class (E1, 5073 regions) was marked by EED, HDAC2 and H3K27ac, but had little H3K27me3. This class was consistent with a previous study that showing that HDACs mark not only inactive genes but also active genes that are poised for transcriptional repression ([@bib55]). A second class (E2, 1830 regions) had strong EED and H3K27ac signals, and H3K27me3 was present but weak. A third class (E3, 1722 regions) was marked by strong and broad EED and H3K27me3, but little H3K27ac. Together, these data suggest that EED may function in a complex involving HDACs, independent of H3K27me3.

Overall, HDAC2 signals did not change in EED deficient CMs ([Figure 4E](#fig4){ref-type="fig"}). This finding was also confirmed by ChIP-qPCR measurement of HDAC2 or HDAC5 enrichment at promoters of genes upregulated in Eed^CKO^ compared to control, revealing no significant difference between HDAC2 or HDAC5 occupancy ([Figure 4F](#fig4){ref-type="fig"} and [Figure 4---figure supplement 1E](#fig4s1){ref-type="fig"}). Given that upregulated genes accounted for a small portion of EED occupied regions, we further analyzed HDAC2 occupancy of genes upregulated, unchanged or downregulated in Eed^CKO^. This analysis reinforced that Eed inactivation did not change HDAC2 occupancy, indicating that HDAC2 accumulation on genomic domains is independent of EED ([Figure 4G](#fig4){ref-type="fig"}). Thus, elevated acetylation on H3K27ac in Eed^CKO^ was unlikely due to decreased HDAC binding.

To identify mechanisms that account for increased H3K27ac at upregulated, EED-occupied genes in Eed^CKO^ CMs, we considered the possibility that EED biochemically regulates HDAC activity. We measured the in vitro deacetylase activity of HDAC2 in the presence of increasing amounts of recombinant EED protein, expressed and affinity purified from S*f*21 cells using a baculovirus expression system. EED protein did not contain detectable contaminating proteins ([Figure 4---figure supplement 2A](#fig4s2){ref-type="fig"}). EED alone had no detectable deacetylase activity, but when added to HDAC2 it augmented HDAC2\'s deacetylase activity by up to threefold ([Figure 4H](#fig4){ref-type="fig"}). Together, the aforementioned data all support a model in which EED represses a subset of its target genes by stimulating HDAC. These results also raise the possibility that EED drives transcriptional repression at least partially by modulating the activity of another class of epigenetic repressors, HDACs.

HDACs functions downstream of EED to direct normal heart maturation {#s2-6}
-------------------------------------------------------------------

Both class I and class II HDACs regulate cardiac gene expression, hypertrophy, and function ([@bib25]; [@bib16]; [@bib52]; [@bib27]; [@bib28]; [@bib60]). Notably, cardiac-restricted deletion of both HDAC1 and HDAC2 caused dilated cardiomyopathy accompanied by upregulation of genes encoding skeletal muscle-specific contractile proteins ([@bib38]). These findings converged with our studies to suggest the hypothesis that EED inactivation caused cardiomyopathy and upregulation of skeletal muscle myofiber genes through loss of HDAC1/2 activity. To test this hypothesis, we asked if overexpression of HDAC1/2 ameliorated the Eed^CKO^ phenotype. Accordingly, we developed AAV9-Tnnt2-HDAC1/2 (abbreviated AAV-HDAC1/2) to direct CM-selective overexpression of HDAC1/2 ([Figure 5---figure supplement 1A--C](#fig5s1){ref-type="fig"}). Remarkably, AAV-HDAC1/2 delivery to P3 Eed^CKO^ mice (CKO-HDAC1/2) normalized systolic dysfunction and cardiomegaly, compared to control treatment with luciferase (CKO-luc; [Figure 5A--C](#fig5){ref-type="fig"}). Heterozygous littermates (Het; *Eed*^fl/+^; *Myh6*^Cre^) were used as unaffected controls. AAV-HDAC1/2 also restored repression of slow twitch sarcomere genes *Acta1* and *Myh7*, and reduced expression of the heart failure marker *Nppa* ([Figure 5D](#fig5){ref-type="fig"}). RNA-seq gene expression measurements showed that out of 863 genes upregulated in Eed^CKO^, 104 were downregulated in the rescue group (adjusted p-value\<0.05 and fold change (CKO-luc/CKO-HDAC1/2) \>1.5; [Figure 5E](#fig5){ref-type="fig"}). Of these 104 genes, 39, 34, and 31 were found in Clusters 1, 2, and 3, respectively.10.7554/eLife.24570.012Figure 5.Re-introduction of HDAC1/2 restored normal heart function.(**A**) AAV-HDAC1/2 rescue of Eed^CKO^. Schematic shows the rescue experiment design. WT and CKO pups were injected with AAV-luc or AAV-HDAC1/2 at P3, and assays were done at 2 months of age. (**B**) Heart function (FS%) was measured at 2 months of age by echocardiography. (**C**) Gross morphology and heart to body weight ratio of hearts from mice at 2 months of age. Bar = 1 mm. (**D**) Analysis of heart failure gene expression. *Acta1*, *Myh7,* and *Nppa* levels in isolated cardiomyocytes were measured by qRTPCR. (**E, F**) Heatmaps (**E**) and box plots (**F**) showing ChIP signals for H3K27ac and H3K27me3 at ±5 kb of TSS of genes upregulated in Eed^CKO^. Row order and cluster labels are the same as [Figure 1J](#fig1){ref-type="fig"}. Comparative analysis of ChIP-seq signals was performed within each cluster as indicated. (**G**) Aggregation plots for H3K27me3 or H3K27ac ChIP-seq signals at ±5 kb of TSS of Eed^CKO^ upregulated genes in Het, CKO+luc, and CKO+HDAC1/2 groups. B,C,D, Unpaired Student's t-test. F, Wilcoxon-Mann-Whitney test. \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.012](10.7554/eLife.24570.012)10.7554/eLife.24570.013Figure 5---figure supplement 1.Effect of over-expression of HDAC1/2 on genome-wide H3K27ac and H3K27me3 accumulation at H3K27ac peaks with increased signal in EedCKO.(**A**) Schematic of AAV9 construct expressing Flag-tagged HDAC1/2 (Flag-HDAC1/2). ITR, Inverted Terminal Repeart. (**B**) Validation of Flag-tagged HDAC1 and HDAC2 protein expression in AAV-treated hearts. Mice were treated with AAV9-Flag-HDAC1/Flag-HDAC2 or AAV9-Flag-EED at P3. Hearts were analyzed at 2 months of age. (**C**) Validation of ectopic and endogenous expression of HDAC1 and HDAC2 proteins in AAV-treated hearts of mice at 2 months of age. (**D-F**) Analysis of H3K27ac and H3K27me3 ChIP signals around all H3K27ac peaks gained in CKO, in het CKO_luc, and CKO_HDAC1/2. Heatmap (**D**) was sorted by descending value of the ratio of H3K27ac signal in CKO_luc to het. (**E**) aggregate plots of H3K27ac and H3K27me3 ChIP signals. (**F**) scatterplot of signal ratios comparing change in EED loss of function to change in HDAC1/2 rescue. Signals are from the peak center ±0.5 kb. (**G**) Immunoblotting and quantification of H3K27ac and H3K27me3 levels in adult cardiomyocytes isolated from hearts of three groups. H3K27ac or H3K27me3 immunoblot signals were normalized to total H3. NS, not significantly different.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.013](10.7554/eLife.24570.013)

We measured the effect of AAV-HDAC1/2 on genome-wide chromatin occupancy of H3K27me3 and H3K27ac by ChIP-seq ([Figure 5E](#fig5){ref-type="fig"}). This revealed that the greater H3K27ac signal observed at the TSS of most of the 863 genes upregulated in Eed^CKO^ was normalized by AAV-HDAC1/2: the ratio of H3K27ac signal in CKO-luc to CKO-HDAC1/2 was ≥1.5 for 460 genes and 1--1.5 for 293 genes, while only 110 were not changed ([Figure 5E](#fig5){ref-type="fig"}). This conclusion was reinforced by comparison of H3K27ac signal between CKO-HDAC1/2 and CKO-luc ([Figure 5F](#fig5){ref-type="fig"}). Within each of the three classes of regions (C1, C2, C3) defined previously based on H3K27ac occupancy and change with Eed inactivation ([Figure 1J](#fig1){ref-type="fig"}), AAV-HDAC1/2 significantly reduced H3K27ac signal. Similar results were observed when all H3K27ac regions that increased in EED loss of function were analyzed, rather than only the TSSs of upregulated genes ([Figure 5---figure supplement 1D--F](#fig5s1){ref-type="fig"}). Normalization of H3K27ac was further supported by calculating each upregulated gene's change in H3K27ac at the TSS in *Eed* loss of function (CKO-luc/het) compared to its change with AAV-HDAC1/2 rescue (CKO-luc/CKO-HDAC1/2; [Figure 5---figure supplement 1F](#fig5s1){ref-type="fig"}, upper panel). For the 104 normalized genes, H3K27ac occupancy was reduced toward control levels. In contrast, no similar change was observed for H3K27me3 ([Figure 5---figure supplement 1F](#fig5s1){ref-type="fig"}, lower panel).

Notably, these changes in H3K27ac occurred despite lack of global H3K27ac level, as measured by immunoblotting ([Figure 5---figure supplement 1G](#fig5s1){ref-type="fig"}). Thus, heart function normalization was not dependent upon broad normalization of H3K27ac but rather on targeted HDAC1/2 activity at specific loci. On the other hand, H3K27me3 was not strongly affected by AAV-HDAC1/2 ([Figure 5E--G](#fig5){ref-type="fig"} and [Figure 5---figure supplement 1D--G](#fig5s1){ref-type="fig"}), consistent with the findings in EED rescue experiments that correction of gene expression and heart function was independent of H3K27me3.

HDAC inhibition antagonized Eed^CKO^ rescue by EED re-expression {#s2-7}
----------------------------------------------------------------

To further probe the requirement of HDAC for EED activity in CMs, we studied the effect of HDAC inhibition on rescue of Eed^CKO^ by AAV-mediated EED re-expression. Neonatal Eed^CKO^ mice were treated with AAV9-EED at P5. They were then treated daily with the broad-spectrum HDAC inhibitor suberanilohydroxamic acid (SAHA) or vehicle control. Het mice transduced with AAV9-luc and then SAHA or vehicle served as additional controls. Consistent with previous reports ([@bib58]), SAHA treatment for 2 months did not adversely effect heart function in the Het controls, nor did it perturb expression of 5 genes (*Acta1, Myl9, Tnni1, Tbx15* and *Mybpc2*) that were aberrantly upregulated in Eed^CKO^. Interestingly, SAHA treatment appeared to block heart function rescue by AAV9-EED re-expression. Two out of five mice died prematurely in the Eed*^CKO^*+EED+SAHA group and were lost to the study. Despite this potential survivor bias, heart function rescue by AAV9-EED tended to impair AAV9-EED rescue in the remaining three mice, although this did not reach statistical significance (p=0.07; [Figure 6A,B](#fig6){ref-type="fig"}). These data suggest that HDAC activity is essential to suppress aberrant gene expression in Eed^CKO^. In line with this, normalized transcription of four out of five genes by EED re-expression in Eed^CKO^ was blocked by SAHA treatment ([Figure 6C](#fig6){ref-type="fig"}). The different effect of SAHA on normal hearts compared to AAV9-EED rescue of EED deficiency suggests that multiple redundant repressive pathways operate in normal heart development, making the HDAC pathway dispensible. However, in AAV-EED rescue of EED deficiency, these redundancies are disrupted, perhaps as a result of perturbations of the chromatin landscape, leaving heart development vulnerable to HDAC inhibition. Collectively, these data indicate that normalization of HDAC activity by EED re-expression was essential for rescue of heart failure in Eed^CKO^.10.7554/eLife.24570.014Figure 6.HDAC inhibition antagonized rescue of Eed^CKO^ by EED re-expression.(**A**) Schematic of the experimental design. (**B**) Heart function was measured by echocardiography as fraction shortening (FS%) in 2-month-old Eed^CKO^ or Het mice that received the indicated treatments. Two of five Eed^CKO^ + EED + SAHA mice died prior to the study endpoint and were not available for echocardiography. (**C**) qRTPCR measurement of five selected genes that were aberrantly expressed in Eed^CKO^ hearts. P-value by Student's t-test. \*p\<0.05; \*\*p\<0.01; NS, not significant.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.014](10.7554/eLife.24570.014)

Altogether, these data demonstrate that HDACs collaborate with EED to mediate postnatal cardiac gene repression required for normal heart development and function. Furthermore, our data indicate that EED functions genetically upstream of HDACs and support a model in which EED maintains transcriptional repression of target genes in post-mitotic cardiomyocytes. Our results demonstrate an essential mechanism of EED repression that is independent of its requirement for PRC2 deposition of H3K27me3 ([Figure 7](#fig7){ref-type="fig"}).10.7554/eLife.24570.015Figure 7.Working model delineates a non-canonical mechanism by which EED represses gene transcription.Two mechanisms for EED repression were operative in the postnatal heart. One subset of repressed genes was occupied by EED and H3K27me3 in WT, and EED inactivation reduced H3K27me3 in association with gain of H3K27ac. Upregulation of these genes in Eed^CKO^ could be due to a combination of loss of H3K27me3 (canonical mechanism). Loss of EED itself with subsequent gain in H3K27ac might also contribute to regulation of these genes. A second subset of repressed genes was also occupied by EED and H3K27me3 in WT, but H3K27me3 was not reduced by EED inactivation. While H3K27me3 may contribute to the repression of these genes in WT, their upregulation in Eed^CKO^ was not attributable to H3K27me3, which was unchanged. Rather, our data suggest that upregulation was directly due to loss of EED itself, with consequent reduction of HDAC activity and gain in H3K27ac. A third subset of genes was occupied by EED but little H3K27me3 in WT. These genes had significant H3K27ac at baseline, which was further increased by Eed inactivation. Thus, these genes may represent a set 'poised' for activation; in WT EED occupancy represses these genes by collaborating with HDAC to limit gene activity. EED inactivation reduces HDAC activity, resulting in H3K27ac accumulation and gene upregulation.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.015](10.7554/eLife.24570.015)

Discussion {#s3}
==========

We found that postnatal loss of EED caused lethal dilated cardiomyopathy associated with ecoptic expression of a slow skeletal muscle gene program. Surprisingly, de-repression of this program was not associated with loss of H3K27me3 at these genes, but rather marked gain of H3K27ac. Moreover, EED depletion caused global increase in histone H3 and H4 acetylation. Our rescue experiments further demonstrated that phenotypic reversal was associated with normalization of H3K27ac but not H3K27me3. Furthermore, we demonstrate a physical and genetic interaction between EED and HDACs that mechanistically accounts, at least in part, for the link between EED loss of function and aberrant H3K27ac accumulation. Together these experiments highlight an H3K27me3-independent repressive activity of EED, and demonstrate that disease caused by aberrant epigenetic regulation can be reversed through epigenetic rewiring.

Gene de-repression in Eed^CKO^ was linked to gain of H3K27ac and not loss of H3K27me3 {#s3-1}
-------------------------------------------------------------------------------------

Previous studies of PRC2 inactivation, performed primarily in cultured cells such as embryonic stem cells, have shown that many de-repressed genes are associated with loss of H3K27me3 ([@bib46], [@bib45]). The role of PRC2 methylation of H3K27me3 in gene repression was further reinforced by studies of Drosophila imaginal discs in which wild-type histone H3 was replaced by a point mutation, H3K27R, that can neither be methylated nor acetylated ([@bib41]). The effect of this H3K27R mutation resembled PRC2 inactivation, suggesting that in this system the major repressive activity of PRC2 is trimethylation of H3K27. However, several lines of evidence from our study indicate that an essential mechanism of PRC2 repression in adult CMs is independent of H3K27me3. First, genes de-repressed by *Eed* inactivation had largely unchanged H3K27me3. This result was robust to the method used to normalize the H3K27me3 ChIP-seq data and was independently validated at selected sites by ChIP-qPCR. Second, AAV-EED rescued heart function without correcting global H3K27me3 levels or occupancy of upregulated gene TSSs. Third, AAV-HDAC1/2 rescued heart function and re-established gene repression without elevating H3K27me3.

Our data indicate that in adult CMs, PRC2 regulation of H3K27ac plays an essential role in repression of a subset of genes. First, gene upregulation in Eed^CKO^ was associated with gain of H3K27ac. Second, AAV-EED rescue correlated with restoration of H3K27ac rather than H3K27me3. Third, AAV-HDAC1/2 rescued function of Eed^CKO^ hearts and normalized H3K27ac but not H3K27me3. HDACs have multiple substrates, including other histone acetylation sites as well as non-histone proteins. Our data do not exclude important effects of HDACs on targets other than H3K27ac, but the close correlation between H3K27ac and cardiac rescue strongly suggests that HDAC acts, at least in part, through H3K27ac. Depletion of essential PRC2 subunits in ES cells and *Drosophila* was previously reported to increase H3K27ac ([@bib40]; [@bib50]; [@bib14]), consistent with the genetic interplay between PRC2 and histone acetylation that we observed in this study. Similarly, dominant negative inhibition of PRC2 by expression of a point mutant of histone H3.3 (H3.3K27M) globally increased H3K27ac ([@bib23]). Furthermore, EED-HDAC2 interaction and HDAC activity were previously reported to be essential for PRC2 repression of selected target loci ([@bib54]). However, the global role of H3K27me3 versus H3K27ac in EED-mediated repression in vivo has remained uncertain. Our study clarifies this relationship in postnatal CMs, by demonstrating that gene de-repression downstream of EED loss of function is closely tied to H3K27ac gain rather than to H3K27me3 loss.

As reviewed above, the canonical dogma is that PRC2 represses genes by depositing H3K27me3. Why might our study have reached a different conclusion? One key difference is the mitotic state of the model systems: whereas the vast majority of studies of PRC2 have been performed in actively cycling cells such as embryonic stem cells and developing embryos, mature CMs have largely exited the cell cycle. Cycling cells require active rewriting of histone marks, so that PRC2 inactivation is rapidly accompanied by widespread H3K27me3 loss. In contrast, adult CMs have relatively stable H3K27me3 and little detectable PRC2 methyltransferase activity. Under these conditions, there is likely a greater opportunity to expose writing-independent activities of EED. Importantly, many cells of adult mammals are either slowly cycling or terminally differentiated, and thus aspects of their epigenetic regulation may more closely resemble adult CMs than cultured cells such as embryonic stem cells.

Remodeling the chromatin landscape to correct heart failure {#s3-2}
-----------------------------------------------------------

Mutations of epigenetic regulators cause congenital heart disease, and abnormalities of the chromatin landscape have been implicated in the pathogenesis of heart failure ([@bib22]; [@bib59]; [@bib16]; [@bib11]; [@bib34]; [@bib38]). The chromatin landscape is not hardwired but rather dynamically constructed through the sequential action of epigenetic regulators, suggesting that perturbation of the normal sequence may irreversibly disrupt the chromatin landscape. Consistent with this expectation, we found that transient loss of EED irrevocably altered the landscape of H3K27me3. EED inactivation also globally increased H3K27ac levels, and gene de-repression was associated with H3K27ac gain on TSS regions of de-repressed genes. This was closely in line with the findings by Margueron and colleagues that transcription and histone modification changes as a consequence of EZH2 loss are predominantly irreversible ([@bib56]). Despite these irreversible changes to the epigenetic landscape, remarkably AAV-EED and AAV-HDAC1/2 were able to successfully remodel the chromatin landscape to functionally correct abnormalities of gene expression and organ function, even without correcting the genome-wide distribution of modified histone marks. These results reveal that it is possible to rehabilitate deregulated gene programs due to distorted chromatin landscapes, which contribute to diseases such as heart failure and congenital heart disease.

Materials and methods {#s4}
=====================

Mice {#s4-1}
----

All animal experiments were performed according to protocols (protocol \#, Lsc-HeAB-1) approved by the Institutional Animal Care and Use Committees of Peking University and Boston Children\'s Hospital. *Eed*^fl^ ([@bib57]) and *Myh6*^Cre^ ([@bib1]) alleles were described previously. 'WT' denotes either *Eed*^fl/fl^; *Myh6*^Cre--^ or *Eed*^fl/+^ genotypes. Mice were injected with AAV (1 × 10^11^ viral particles/gram body weight) by intraperitoneal or intravascular injection into pups and adults, respectively. Mice were intraperitoneally injected with SAHA (Sigma, 25 mg/kg/day) for the period of time as indicated. Echocardiography was conducted in either conscious or lightly anesthetized mice (isoflurane) using a Vevo 2100 imaging system (VisualSonics, Inc). Adult cardiomyocytes were isolated using type II collagenase in the Langendorff retrograde perfusion mode ([@bib39]), and cardiomyocytes purity was evaluated for by co-immunostaining for cardiomyocyte mark Troponin i 3 (TNNI3) and DAPI. Isolated cardiomyocytes will be used only if more than 95% cells are positive for TNNI3.

Cell culture {#s4-2}
------------

HL-1 cardiomyocyte-like cells ([@bib10]) were cultured and validated as described previously ([@bib19]), and determined as free of mycoplasma contamination. Fully confluent HL-1 cells were transfected using RNAiMax (Life Technoligies) with a pool of TriFECTa Dicer-Substrate siRNAs (DsiRNAs) (Integrated DNA Technologies) against Eed (conserved in both mouse and rat). Scrambled DsiRNA was used as the control. Sequences are provided ([Supplementary file 2A](#SD2-data){ref-type="supplementary-material"}). Cells were analyzed 72 hr after transfection. Transfection efficiency was verified to be more than 90% using fluorescently labeled control duplex as the indicator.

Western blot {#s4-3}
------------

Cells were lysed in Nuclear Lysis Buffer (NLB, 50 mM Tris-Hcl pH8.0, 150 mM NaCl, 1% Nonidet P-40 (NP40), 1 mM EDTA, and fresh 1 mM PMSF and protease inhibitor cocktail (PIC)) for 30 mins, and 1% SDS was added before homogenization on QIAshredder columns. Equal amounts of proteins were resolved on 7.5% or 10% SDS-polyacrylamide gels and immunoblotted with primary antibodies listed ([Supplementary file 2B](#SD2-data){ref-type="supplementary-material"}). EED antibody was a kind gift from D. Reinberg ([@bib37]).

Protein-protein interactions {#s4-4}
----------------------------

Co-immunoprecipitation was performed as described ([@bib22]) with minor modifications. Nuclei were isolated using Hypotonic Lysis Buffer (20 mM HEPES pH 7.5, 10 mM KCl, 1 mM EDTA, 0.1 mM Na3VO4, 0.1 mM 0.2% (vol/vol) NP-40, 10% (vol/vol) glycerol plus PIC) and then resuspended in lysis buffer (50 mM Tris-HCl pH 8.0, 150 mM NaCl, 0.5% NP-40, 1 mM EDTA, and fresh 1 mM PMSF and PIC). Lysates were treated with 20 U of Benzonase nuclease (Stratagene) for 1 hr at 4°C. After centrifugation at 16,000 x g for 20 min at 4°C, soluble materials were kept as nuclear extracts. Nuclear extracts were precleared with Protein G beads before incubation with 5 µg of the indicated antibodies prebound to Protein G beads or Anti-Flag Affinity gel (Sigma, A2220) or Anti-HA High-Affinity Matrix (Roche, 12013819001) for 4 hr or overnight at 4°C. After washing three times with lysis buffer, precipitated proteins were recovered by elution in the sample buffer.

In vitro HDAC activity assay {#s4-5}
----------------------------

In vitro deacetylation assay was performed using a colorimetric immunoassay for deacetylated histones (Epigentek, P-4034--96). Fifty nanogram recombinant HDAC2 (Active Motif 31343) and 0--100 ng recombinant EED (Cayman Chemical 10628) or bovine serum albumin were incubated at 37°C for 1 hr, and determined from the absorbance at 450 nm.

ChIP and ChIP-seq {#s4-6}
-----------------

Antibody-based ChIP was performed as described ([@bib21]) using antibodies listed ([Supplementary file 2B](#SD2-data){ref-type="supplementary-material"}). EED ChIP-seq was performed in adult cardiomyocytes using bioChIP method as described previously ([@bib22]). Briefly, BirA mice were injected with AAV expressing the cardiomyocyte-specific promoter cTNT driving EED in fusion with FLAG and bio (fbio) epitope tags, where bio is 23 amino-acid sequence specifically biotinylated by the enzyme BirA, and cardiomyocytes were harvested for bioChIP (ChIP pulldown through streptavidin beads) as indicated. ChIP-qPCR values were expressed as fold-enrichment.

Illumina ChIP-seq libraries were prepared as described ([@bib18]) from purified cardiomyocytes, sequenced on an Illumina Hiseq 2500, and analyzed as described ([@bib18]). Briefly, filtered reads were aligned to the July 2007 assembly of the mouse genome (NCBI 37, mm9) using the Burrows-Wheeler Aligner (BWA) ([@bib33]) with default settings. Reads with no more than 4% (2 bp) mismatches and uniquely mapped to reference genome were kept for downstream analyses. The sequencing data are summarized here ([Supplementary file 3](#SD3-data){ref-type="supplementary-material"}).

Peaks were identified using MACS2 ([@bib61]) (version 2.1.0), with the parameter settings (\--keep-dup=1; \--broad). Peaks were assigned to the gene with the closest TSS within 100 kb. Proximal was defined within ±5 kb of a gene\'s TSS. Remaining regions were defined as distal. Cardiac enhancers were identified by H3K27ac peaks using adult heart H3K27ac ChIP-seq data ([@bib18]). BigWig files normalized per 10 million aligned reads were viewed using the Integrative Genomics Viewer (IGV) (version 2.3.59) ([@bib43]).

ChIP and input reads were normalized to 10 million total aligned reads for H3K27ac, EED, and HDAC2. To reduce background signals for H3K27me3 in Eed^CKO^ vs WT, we firstly implemented a normalizing factor quantified through ChIP experiments (the relative levels of ChIP derived DNA) to the reads intensities in Eed^CKO^ and WT ([@bib14]). To further exclude the bias due to normalization, we further chose the second normalization manner, yielding the similar results ([@bib29]). Simply, H3K27me3 ChIP signals were standardized using z-score transformation of ChIP reads by calculating mean and standard deviation of each dataset without all peak regions, presumably called background vs input. DANPOS (version 2.2.2) ([@bib9]) was used to calculate H3K27me3 and H3K27ac signals (ChIP reads minus input reads, kept only if the value \>0) for aggregate plots and box plots. H3K27ac and H3K27me3 signals were calculated at 20 bp intervals and plotted using R (version 3.2.2) and ggplot2 (version 1.0.1). Genome-wide distributions of H3K27me3 and H3K27ac signals were determined by counting ChIP signals within non-overlapping 1 kb wide windows tiled over the mouse genome. The box plots were generated using the average ChIP signals of ±5 kb of genes\' TSS.

RNA expression {#s4-7}
--------------

RNA was prepared from purified adult cardiomyocytes as described ([@bib20]). mRNA sequencing library was prepared with Script-seq v2 (Illumina), and sequenced on Illumina Hi-seq 2000 (PE100). The resulting sequences were mapped to the mouse genome mm9 with STAR ([@bib13]). Transcripts per million reads (TPM) and Fragments per kilobase of exon per million fragments (FPKM) were generated for further quantification by RSEM and Bowtie 2 ([@bib30]; [@bib32]), and differentially expressed genes were called with edgeR (v3.14.0) with the following criteria: adjusted p-value\<0.05 and fold change (FC) \>1.5 or \<0.67. The gene ontology (GO) enrichment analysis of DEGs was performed using Metascape ([@bib51]). The top six GO terms with p-value\<0.001 in the 'biological process' category were used.

Quantitative PCR {#s4-8}
----------------

Real-time PCR was used to measure relative ChIP enrichment or gene expression. Quantitative PCR was performed using Power Sybr Green Master Mix (Life Technologies). Primer sequences are listed here ([Supplementary file 2C](#SD2-data){ref-type="supplementary-material"}). ChIP-qPCR values were expressed as fold-enrichment.

Statistical analysis {#s4-9}
--------------------

Student's two-tailed *t*-test was used to determine the significance of differences between two groups in all qPCR assays. For bar charts, data are presented as mean ± SEM. For violin plots, the center line indicates the median. Wilcoxon-Mann-Whitney test was used to compare aggregate curves and violin-bar plots. Statistical significance was indicated with: \*p\<0.05; \*\*p\<0.01; \*\*\*p\<0.001.

Accession codes {#s4-10}
---------------

The high-throughput data used in this study are available through the Cardiovascular Development Consortium Server at <https://b2b.hci.utah.edu/gnomex/>. Sign in as guest and go to experiment \#410R. The data have also been deposited at GEO (accession number GSE73771).
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###### The list of next-generation sequencing data.
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Major datasets {#s7}
--------------

The following dataset was generated:

Ai S,Peng Y,He A,2016,Transcriptional repression by non-canonical EED stimulation of histone deacetylase activity is required for heart maturation independently of H3K27me3,<https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE73771>,Publicly available at the NCBI Gene Expression Omnibus(accession no: GSE73771)

10.7554/eLife.24570.022

Decision letter

Lee

Jeannie T

Reviewing editor

Massachusetts General Hospital

,

United States

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article \"EED orchestration of heart maturation through interaction with HDACs is H3K27me3-independent\" for consideration by *eLife*. Your article has been favorably evaluated by Kevin Struhl (Senior Editor) and three reviewers, one of whom is a member of our Board of Reviewing Editors. The following individuals involved in review of your submission have agreed to reveal their identity: Mauro Calabrese (Reviewer \#3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

First: There is general agreement that your manuscript is a potentially important study and that the findings you report are surprising. There is enthusiasm for publishing this paper in *eLife*. However, the surprising and significant conclusions rest heavily on there being no cardiac cell division after birth to dilute away the H3K27 mark. Recent papers suggest that heart cells can and do divide after birth. The authors must test this to see if cell division is taking place. Current models are that non-dividing cells should be able to maintain H3K27me3 without PRC2, which is why the paper concludes that PRC2 must have another function independent of H3K27me3 in light of the cardiomyopathy seen after EED deletion.

Second: The reviewers also commented that the Text understated the loss of the histone mark. One third of derepressed genes did show loss of H3K27me3. How did this take place? This could have been due to cell division and passive loss of the histone mark. Quantitative measurements with statistical testing should be performed for known polycomb targets in heart muscle.

Third: there is general concern that the EED KO may not be a true null. Peptides can still be seen in Western. It would be important to determine whether the mutant protein truly has no activity.

Finally: your paper proposes a direct mechanistic link between EED and HDAC. One reviewer suggested the excellent idea of treating cardiomyocytes with HDAC-inhibitors to see if the same target genes are upregulated as in the EED CKO. If so, the results would speak for a common mechanism.

For publication, we would like to see these points and related points addressed in a revised manuscript. If you choose to revise your manuscript, we would also require a reviewer-link to the GEO data for this study. We hope to see a revised manuscript within 2-3 months, although the nature of the requested experiments may require you to take more time.

*Reviewer \#1:*

This is a potentially important study that proposes that depleting EED (and therefore PRC2) in postnatal cardiomyocytes results in a lethal dilated cardiomyopathy with loss of silencing of myocardial gene program. This finding is surprising because non-dividing cells are thought to be able to maintain H3K27me3 without PRC2. The authors conclude that EED has a non-canonical function that is independent of its H3K27 methylation activity. The paper reports exciting findings. However, there are two concerns that must be addressed for publication.

1\) Postnatal cardiomyocytes have been shown in recent studies to proliferate. Please consult (as one example): Naqvi N, Li M, Calvert JW, Tejada T, Lambert JP, Wu J, Kesteven SH, Holman SR, Matsuda T, Lovelock JD, et al. 2014. A proliferative burst during preadolescence establishes the final cardiomyocyte number. Cell 157: 795-807. The authors\' findings relating to an EED deletion could be explained if there is proliferation in the postnatal cardiomyocytes. In this case, there would not be a \"non-canonical\" function of PRC2, and the authors would have to tone down their conclusions considerably. The paper may still be publishable without this dramatic conclusion.

2\) The authors\' data suggest that there is in fact some loss of H3K27me3. This would be consistent with continued (though limited) proliferation of cardiomyocytes after birth. I think the authors underestimated the depletion of the H3K27me3 mark.

*Reviewer \#2:*

In this manuscript, the authors describe the interesting observation that EED is critical for heart maturation and propose a novel mechanism, in which EED does not repress its target genes via its chanonical role in PRC2 through applying the H3K27me3 mark, but rather through affecting histone acetylation by modulating HDAC activity. The authors present clear evidence for a striking phenotype, and provide a comprehensive analysis with convincing rescue experiments showing a clear role for EED and HDACs. However, some discrepancies in the data, like for example opposing results for recruitment of HDACs by EED depending on the assay (EED loss of function -- no effect vs. sufficiency via EED tethering), need to be addressed before firm mechanistic claims linking EED with HDAC activity can be made.

1\) [Figure 1A](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1H](#fig1s1){ref-type="fig"}: There is still a remaining Eed transcript detectable in Eed^CKO^ mice. The Western Blot is cut, so it is not visible, if there is a remaining Eed protein of reduced size. The authors should show the entire Western Blot and quantify the remaining RNA-levels based on qPCR (both for wt and CKO transcript levels). It is possible that a truncated Eed protein could still have a remaining function in the CKO allele, or incomplete deletion by the Cre-driver (some remaining protein visible in [Figure 1A](#fig1){ref-type="fig"}) could explain the leftover H3K27me3 signal. A truncated EED-protein could also have different hypomorphic functionalities, for example related to gene repression, than a complete null would have. Therefore, it is important to clarify, if the presented CKO allele is a complete functional null or not.

2\) [Figure 4H--K](#fig4){ref-type="fig"}: In [Figure 4D--G](#fig4){ref-type="fig"} the authors have demonstrated that EED does not play a significant role in vivo in recruiting HDAC2 to chromatin. However, artificial tethering of EED to ectopic sites led to strong HDAC2 recruitment by dCas9-EED ([Figure 4J](#fig4){ref-type="fig"}). Could this be evidence for a remaining EED-protein in the CKO allele that might still able to recruit HDAC2 but not to stimulate its activity (related to my concern mentioned in point 1)? It would be interesting to know, if a complete Eed KO shows similar effects on HDAC recruitment/activity. Could this be tested in a full EED KO or knockdown cell line?

3\) [Figure 5](#fig5){ref-type="fig"}: While it is interesting that overexpression of HDAC1/2 leads to a partial rescue (changes in H3K27ac look not very strong after HDAC overexpression) of the EED CKO phenotype, a complementary proof would be a loss of function experiment for HDAC activity in heart muscle cells. It would make the argument more convincing, if treatment of wt heart muscle cells with HDAC-inhibitors could show, if the same genes, which are upregulated in EED CKO, also become upregulated after HDAC inhibition. This would strengthen the link between EED and HDAC activity more directly and make the proposed model more convincing.

*Reviewer \#3:*

This is an impressive study that demonstrates the functions and mechanisms of Eed-mediated gene regulation in the developing heart. The authors find that deletion of Eed during heart development results in cardiomyopathy concomitant with upregulation of several slow-twitch myofiber genes. A battery of genomic profiling experiments performed in wild-type, mutant, and Eed or HDAC rescued cardiomyocytes, demonstrate that Eed recruits and/or stimulates histone deacetylase activity at key target genes to acutely repress their expression during heart maturation. The major surprise is that this repressive effect is caused by recruitment and/or stimulation of HDAC activity, and is independent of major changes in H3K27me3 at two-thirds of target genes. The experiments presented are thorough and extensive. The results corroborate prior works that have linked PRC2 complex to HDACs, and should be of broad interest to many researchers. I think the manuscript could almost be published as is.

1\) From a mechanistic standpoint, the incomplete loss of H3K27me3 upon EED knockout left me scratching my head, because loss of Eed causes a global loss of H3K27me3 in just about every other cell type in which an Eed deletion has been performed. The authors suggest that the lack of complete H3K27me3 loss upon Eed deletion is due to the fact that the modification is very stable in cells that do not divide, like cardiomyocytes.

An alternate explanation for the persistence of H3K27me3 upon Eed deletion is that the knockout is incomplete and/or there remains some functional PRC2 in the cells. For example, the Cre-driver may not KO Eed in 100% of cells. Or (less likely), maybe Ezh2 can be recruited to some sites independently of Eed.

The authors should do a few simple characterization experiments in WT vs. CKO cardiomyocytes to clear up the uncertainty. A PCR-based assay to detect the floxed vs. deleted allele, and an immunostain to Eed would be informative. Also, Ezh2 is known to be destabilized in the absence of Eed. Thus, a western blot and immunostain to Ezh2 would also be informative.

Also, does the Eed deletion generate a premature truncation of the protein? Or is the deletion in frame?

2\) Along the lines of 1, the authors should better explain the Eed western blot in [Figure 1A](#fig1){ref-type="fig"}. Why are there three bands for Eed? The largest band does not disappear upon EED CKO (it is marked by an \* in the figure). Could this be residual Eed? Can the authors use another antibody to rule out if it is a non-specific band, and not an alternate Eed isoform?

10.7554/eLife.24570.023

Author response

*First: There is general agreement that your manuscript is a potentially important study and that the findings you report are surprising. There is enthusiasm for publishing this paper in eLife. However, the surprising and significant conclusions rest heavily on there being no cardiac cell division after birth to dilute away the H3K27 mark. Recent papers suggest that heart cells can and do divide after birth. The authors must test this to see if cell division is taking place. Current models are that non-dividing cells should be able to maintain H3K27me3 without PRC2, which is why the paper concludes that PRC2 must have another function independent of H3K27me3 in light of the cardiomyopathy seen after EED deletion.*

Our main finding is that upregulation of the majority of genes in postnatal cardiomyocyte EED knockout was not linked to loss of H3K27me3. This observation is independent of whether cardiomyocyte proliferate or not. However, the paucity of postnatal cardiomyocyte proliferation is likely an important reason that our data differs from studies of EED in cell lines or proliferating cell types.

Although Naqvi et al. (PMID:24813607) suggested a burst of cardiomyocyte proliferation in mouse preadolescence (2 weeks after birth), this finding has not been reproduced by the work of four independent groups using multiple independent methods (PMID: 24876275, 26544945, 26544927, and 26472817). The general consensus currently is that there is detectable but limited cardiomyocyte proliferation in the postnatal heart (for example, PMID 17660827, 19342590, 23222518, in addition to the 4 studies cited in the previous sentence). The large majority of murine cardiomyocytes undergo a final round of nuclear division within the first postnatal week of life, and then terminally exit the cell cycle. In the mature adult heart, there is general agreement that the rate of cardiomyocyte turnover is low (CM turnover of 0.7-1% per year in adult mouse and human). We performed immunofluorescent staining for phosphohistone H3 (pH3, M-phase marker) of heart sections at three different postnatal ages and confirmed that there is little cardiomyocyte cell cycle activity after the first postnatal week ([Author response image 1](#fig8){ref-type="fig"}). Given the large body of data on this topic in the literature and the elaborate methods (C14 carbon dating; imaging mass spectrometry; genetic pulse-labeling) that have been employed to reach the current consensus, we felt that including these data in this paper would not add to the paper or to the overall literature on this subject.10.7554/eLife.24570.019Author response image 1.Examination of cariomyocyte proliferation rate in neonatal heart.Immunostaining and quantification of phosphorylated histone H3 (pH2; red) as a marker for M-phase in hearts at P0, P5 and P18 cardiomyocytes (TNN13, green). Scale bar = 20 μm.**DOI:** [http://dx.doi.org/10.7554/eLife.24570.019](10.7554/eLife.24570.019)

*Second: The reviewers also commented that the Text understated the loss of the histone mark. One third of derepressed genes did show loss of H3K27me3. How did this take place? This could have been due to cell division and passive loss of the histone mark. Quantitative measurements with statistical testing should be performed for known polycomb targets in heart muscle.*

As noted by the reviewers, 1/3 of upregulated genes had H3K27me3 loss, whereas 2/3 of upregulated genes had retained H3K27me3. This variation in H3K27me3 levels strongly argues that loss of H3K27me3 is not due to passive dilution during proliferation. We have done separate experiments that measure locus-specific histone turnover in cardiomyocytes, which is possible because of their low turnover rate. We observed that cardiomyocytes display finely-regulated locus-specific histone turnover. This separate manuscript is currently in preparation.

In the revised manuscript, we have made more clear that 1/3 of genes are upregulated and lose H3K27me3, consistent with the canonical model of PRC2-mediated repression through H3K27me3 deposition. We grouped the upregulated genes into clusters based on their H3K27me3 signal in WT and Eed^CKO^ ([Figure 1J](#fig1){ref-type="fig"}). C1 corresponds to the cluster with gene upregulation and H3K27me3 loss. The majority of genes fall into C2 and C3, which do not show this canonical association. As shown in [Figure 1L](#fig1){ref-type="fig"}, we quantitatively compared H3K27me3 signal between WT and Eed^CKO^ within each cluster with appropriate statistical testing to better demonstrate the behavior of H3K27me3 in C1 vs C2 and C3.

In the revision, we also performed quantitative analysis of H3K27me3 levels on known polycomb targets (defined by ± 10 kb of gene TSS) in cardiomyocytes as suggested by the editor and reviewers ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). We found that median H3K27me3 levels were reduced only in EED target genes among the quartile of upregulated genes with the strongest H3K27me3 in WT ([Figure 1---figure supplement 2M](#fig1s2){ref-type="fig"}), again indicating that H3K27me3 loss was only seen in a minority of upregulated genes.

*Third: there is general concern that the EED KO may not be a true null. Peptides can still be seen in Western. It would be important to determine whether the mutant protein truly has no activity.*

In [Figure 1A](#fig1){ref-type="fig"}, the above 75 kDa, indicated by asterisk, is larger than the calculated full-length molecular weight of 60 kDa and is a non-specific band. The remaining EED detected in EED-CKO is likely due to the signals from non-cardiomyocytes of P0 and P5 heart apex used for Western blot and RT-qPCR ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). While [Figure 1A](#fig1){ref-type="fig"} used whole heart apex, the rest of the manuscript used isolated adult cardiomyoctes with \>95% purity for Western blots, RNA analysis, and ChIP-seq.

In the EED conditional allele, the floxed exons are 3-6, which contain the critical WD-repeat domain of EED that binds to nucleosomes and EZH2. This same floxed allele was tested by Stuart Orkin's lab and demonstrated to be functionally null (Xie, et al., Cell Stem Cell, 2014, PMID: 24239285). In RNA-seq of purified cardiomyocytes, exons 3-6 were not detectably expressed, confirming high efficiency gene ablation ([Figure 1---figure supplement 2I](#fig1s2){ref-type="fig"}). We further verified the nearly complete excision of the floxed allele by PCR analysis with DNA from purified cardiomyocytes ([Figure 1---figure supplement 2H](#fig1s2){ref-type="fig"}). Based on these data, we are confident that there is no residual, functional EED protein in the large majority of adult cardiomyocytes used for the RNA-seq and ChIP-seq experiments.

*Finally: your paper proposes a direct mechanistic link between EED and HDAC. One reviewer suggested the excellent idea of treating cardiomyocytes with HDAC-inhibitors to see if the same target genes are upregulated as in the EED CKO. If so, the results would speak for a common mechanism.*

Our model is that EED stimulates HDAC activity, and therefore HDAC inhibition might mimic some of the features of EED-CKO. As suggested by the editor and reviewers, we treated control (Het + AAV-luc) mice with the broad spectrum HDAC inhibitor SAHA ([Figure 6](#fig6){ref-type="fig"}). SAHA did not significantly affect heart function or derepress genes that were upregulated in EED-CKO. These data indicate that EED-HDAC is not required in normal cardiomyocyte maturation, possibly due to multiple, redundant gene repressive mechanisms. However, when EED-CKO mice were rescued with AAV9-EED, rescue was blocked by SAHA ([Figure 6](#fig6){ref-type="fig"}). This suggests that transient EED loss of function disrupts the chromatin landscape and multiple gene repressive mechanisms. Whereas re-expression of EED can restore gene repression, this process depends on HDAC activity.

*For publication, we would like to see these points and related points addressed in a revised manuscript. If you choose to revise your manuscript, we would also require a reviewer-link to the GEO data for this study. We hope to see a revised manuscript within 2-3 months, although the nature of the requested experiments may require you to take more time.*

We have deposited the data to GEO and have supplied a reviewer link in the revised manuscript.

*Reviewer \#1:*

*This is a potentially important study that proposes that depleting EED (and therefore PRC2) in postnatal cardiomyocytes results in a lethal dilated cardiomyopathy with loss of silencing of myocardial gene program. This finding is surprising because non-dividing cells are thought to be able to maintain H3K27me3 without PRC2. The authors conclude that EED has a non-canonical function that is independent of its H3K27 methylation activity. The paper reports exciting findings. However, there are two concerns that must be addressed for publication.*

*1) Postnatal cardiomyocytes have been shown in recent studies to proliferate. Please consult (as one example): Naqvi N, Li M, Calvert JW, Tejada T, Lambert JP, Wu J, Kesteven SH, Holman SR, Matsuda T, Lovelock JD, et al. 2014. A proliferative burst during preadolescence establishes the final cardiomyocyte number. Cell 157: 795-807. The authors\' findings relating to an EED deletion could be explained if there is proliferation in the postnatal cardiomyocytes. In this case, there would not be a \"non-canonical\" function of PRC2, and the authors would have to tone down their conclusions considerably. The paper may still be publishable without this dramatic conclusion.*

We addressed this comment in detail in the summary critique (point \#1). The main observation that gene upregulation was not associated with H3K27me3 loss at 2/3 of genes is not dependent on whether or not cardiomyocytes proliferate. The terminal differentiation of postnatal CMs is relevant to the study because it provides a potential explanation for why this non-canonical mechanism is not observed in intensively studied cell types such as ESCs and cancer cell lines, where cell proliferation demands PRC2 deposition of new H3K27me3 and hence emphasizes this aspect of PRC2 function.

Although Naqvi et al. (PMID:24813607) showed a burst of cardiomyocyte proliferation in mouse preadolescence (2 weeks after birth), this result has not been reproduced by four independent groups using multiple independent approaches (PMID: 24876275, 26544945, 26544927, and 26472817). The general consensus currently is that there is detectable but limited cardiomyocyte proliferation in the postnatal heart. The large majority of murine cardiomyocytes undergo a final round of nuclear division within the first postnatal week of life, and then terminally exit the cell cycle. In the mature adult heart, there is general agreement that the rate of cardiomyocyte turnover is low (CM turnover of 0.7-1% per year in adult mouse and human). [Author response image 1](#fig8){ref-type="fig"} shows additional data that cardiomyocytes have largely exited the cell cycle after the first postnatal week. We do not rule out all proliferation-related dilution of H3K27me3 in EED-CKO, but it is likely to make a small contribution to the loss of H3K27me3.

We observed that H3K27me3 is retained at some sites and lost at others. This cannot be accounted for simply by proliferation-related dilution, and further indicates that other mechanisms are responsible for H3K27me3 loss. We have studied histone dynamics in postnatal cardiomyocytes extensively and are preparing a separate manuscript on this topic. However, it is outside of the scope of the present study.

*2) The authors\' data suggest that there is in fact some loss of H3K27me3. This would be consistent with continued (though limited) proliferation of cardiomyocytes after birth. I think the authors underestimated the depletion of the H3K27me3 mark.*

We agree that about 1/3 of derepressed genes have reduced H3K27me3. On the other hand, 2/3 of these genes retain H3K27me3, which was quantified in [Figure 1L](#fig1){ref-type="fig"} and also in this revision ([Figure 1---figure supplement 2M](#fig1s2){ref-type="fig"}). This differential retention of H3K27me3 cannot be accounted for by passive dilution during proliferation and strongly argues for other mechanisms of H3K27me3 loss. We have done separate experiments that measure locus-specific histone turnover in cardiomyocytes, which is possible because of their low turnover rate. We observed that cardiomyocytes display finely-regulated locus-specific histone turnover. This separate manuscript is currently in preparation.

The major focus of this manuscript is understanding the mechanism of derepression of the 2/3 of genes that retained H3K27me3.

*Reviewer \#2: In this manuscript, the authors describe the interesting observation that EED is critical for heart maturation and propose a novel mechanism, in which EED does not repress its target genes via its chanonical role in PRC2 through applying the H3K27me3 mark, but rather through affecting histone acetylation by modulating HDAC activity. The authors present clear evidence for a striking phenotype, and provide a comprehensive analysis with convincing rescue experiments showing a clear role for EED and HDACs. However, some discrepancies in the data, like for example opposing results for recruitment of HDACs by EED depending on the assay (EED loss of function -- no effect vs. sufficiency via EED tethering), need to be addressed before firm mechanistic claims linking EED with HDAC activity can be made. 1) [Figure 1A](#fig1){ref-type="fig"} and [Figure 1---figure supplement 1H](#fig1s1){ref-type="fig"}: There is still a remaining Eed transcript detectable in EedCKO mice. The Western Blot is cut, so it is not visible, if there is a remaining Eed protein of reduced size. The authors should show the entire Western Blot and quantify the remaining RNA-levels based on qPCR (both for wt and CKO transcript levels). It is possible that a truncated Eed protein could still have a remaining function in the CKO allele, or incomplete deletion by the Cre-driver (some remaining protein visible in [Figure 1A](#fig1){ref-type="fig"}) could explain the leftover H3K27me3 signal. A truncated EED-protein could also have different hypomorphic functionalities, for example related to gene repression, than a complete null would have. Therefore, it is important to clarify, if the presented CKO allele is a complete functional null or not.*

In [Figure 1A](#fig1){ref-type="fig"}, the band at 75 kDa, indicated by an asterisk, is larger than the expected full-length molecular weight of 60 kDa and represents a non-specific signal. The remaining EED detected in EED CKO is likely due to the signals from non-cardiomyocytes of P0 and P5 heart apex used for Western blot and RT-qPCR ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). While [Figure 1A](#fig1){ref-type="fig"} used whole heart apex, the rest of the manuscript used isolated adult cardiomyoctes with \>95% purity for the other Western blots, RNA analysis, and ChIP-seq. In the EED conditional allele, the floxed exons are 3-6, which contain the critical WD-repeat domain of EED that binds to nucleosomes and EZH2. This same floxed allele was tested by Stuart Orkin's lab and demonstrated to be functionally null (Xie, et al., Cell Stem Cell, 2014, PMID: 24239285). In RNA-seq of purified cardiomyocytes, exons 3-6 were not detectably expressed, confirming high efficiency gene ablation ([Figure 1---figure supplement 2I](#fig1s2){ref-type="fig"}). We further verified the nearly complete excision of the floxed allele by PCR analysis of DNA from purified cardiomyocytes ([Figure 1------figure supplement 2H](#fig1s2){ref-type="fig"}). Based on these data, we are confident that there is no residual, functional EED protein in the large majority of adult cardiomyocytes used for the RNA-seq and ChIP-seq experiments.

*2) [Figure 4H-K](#fig4){ref-type="fig"}: In [Figure 4D-4G](#fig4){ref-type="fig"} the authors have demonstrated that EED does not play a significant role in vivo in recruiting HDAC2 to chromatin. However, artificial tethering of EED to ectopic sites led to strong HDAC2 recruitment by dCas9-EED ([Figure 4J](#fig4){ref-type="fig"}). Could this be evidence for a remaining EED-protein in the CKO allele that might still able to recruit HDAC2 but not to stimulate its activity (related to my concern mentioned in point 1)? It would be interesting to know, if a complete Eed KO shows similar effects on HDAC recruitment/activity. Could this be tested in a full EED KO or knockdown cell line?*

We thank the reviewer for this critical point. Although the tethering experiment demonstrated that EED can stimulate local histone deacetylation, it is confusing because it appears to contradict the in vivo data that show that EED is dispensable for recruiting HDAC2 to chromatin. The cellular and chromatin contexts of these experiments are quite different and we do not believe the results are incompatible. For instance, the tested genes do not naturally have HDAC2 or EED occupancy, whereas the in vivo experiment was a loci that do have endogenous HDAC2 and EED occupancy. Nevertheless, because this experiment is confusing, we removed it from the revised manuscript.

*3) [Figure 5](#fig5){ref-type="fig"}: While it is interesting that overexpression of HDAC1/2 leads to a partial rescue (changes in H3K27ac look not very strong after HDAC overexpression) of the EED CKO phenotype, a complementary proof would be a loss of function experiment for HDAC activity in heart muscle cells. It would make the argument more convincing, if treatment of wt heart muscle cells with HDAC-inhibitors could show, if the same genes, which are upregulated in EED CKO, also become upregulated after HDAC inhibition. This would strengthen the link between EED and HDAC activity more directly and make the proposed model more convincing.*

We thank the reviewer for this excellent suggestion. We treated control (Het + AAV-luc) mice with the broad spectrum HDAC inhibitor SAHA ([Figure 6](#fig6){ref-type="fig"}). SAHA did not significantly affect heart function or derepress genes that were upregulated in EED-CKO. These data indicate that EED-HDAC is not required in normal cardiomyocyte maturation, possibly due to multiple, redundant gene repressive mechanisms. However, when EED-CKO mice were rescued with AAV9-EED, rescue was blocked by SAHA ([Figure 6](#fig6){ref-type="fig"}). This suggests that transient EED loss of function disrupts the chromatin landscape and multiple gene repressive mechanisms. Whereas re-expression of EED can restore gene repression, this process depends on HDAC activity.

*Reviewer \#3:*

*\[...\] 1) From a mechanistic standpoint, the incomplete loss of H3K27me3 upon EED knockout left me scratching my head, because loss of Eed causes a global loss of H3K27me3 in just about every other cell type in which an Eed deletion has been performed. The authors suggest that the lack of complete H3K27me3 loss upon Eed deletion is due to the fact that the modification is very stable in cells that do not divide, like cardiomyocytes.*

*An alternate explanation for the persistence of H3K27me3 upon Eed deletion is that the knockout is incomplete and/or there remains some functional PRC2 in the cells. For example, the Cre-driver may not KO Eed in 100% of cells. Or (less likely), maybe Ezh2 can be recruited to some sites independently of Eed.*

We demonstrated that *Ezh*2 is below detection level by Western blot in adult cardiomyocytes (He, et al. 2012, Genes & Dev.). We believe that H3K27me3 persists largely because of low histone turnover rates, i.e. H3K27me3 that was deposited prior to EED deletion persists for weeks in the absence of de novo deposition. This view is supported by a separate study in which we have studied histone turnover in terminally differentiated cardiomyocytes (in preparation). In the revised manuscript, we provide several additional lines of evidence to show that Cre-mediated EED recombination was highly efficient in CMs ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}; [Figure 1---figure supplement 2G--I](#fig1s2){ref-type="fig"}).

*The authors should do a few simple characterization experiments in WT vs. CKO cardiomyocytes to clear up the uncertainty. A PCR-based assay to detect the floxed vs. deleted allele, and an immunostain to Eed would be informative. Also, Ezh2 is known to be destabilized in the absence of Eed. Thus, a western blot and immunostain to Ezh2 would also be informative.*

In RNA-seq of purified cardiomyocytes, exons 3-6 were not detectably expressed, confirming high efficiency gene ablation ([Figure 1---figure supplement 2I](#fig1s2){ref-type="fig"}). We further verified the nearly complete excision of the floxed allele by PCR analysis with DNA from purified cardiomyocytes ([Figure 1---figure supplement 2H](#fig1s2){ref-type="fig"}). The immunostaining data showed loss of H3K27me3 signal in CMs ([Figure 1---figure supplement 2G](#fig1s2){ref-type="fig"}). Unfortunately, there is no commercial antibody suitable for EED immunofluorescent staining that we are aware of. Based on these data, we are confident that there is no residual, functional EED protein in the large majority of adult cardiomyocytes used for the RNA-seq and ChIP-seq experiments. As Ezh2 expression is very low in wild-type adult cardiomyocytes at the transcript level (He et al. 2012 Circ Res.), the proposed experiment on EZH2 would not be informative.

*Also, does the Eed deletion generate a premature truncation of the protein? Or is the deletion in frame?*

The floxed exons are 3-6, which contain the critical WD-repeat domain of EED that binds to nucleosome and EZH2. This same floxed allele was tested by Stuart Orkin's lab and demonstrated to be functionally null (Xie, et al., Cell Stem Cell, 2014, PMID: 24239285). Their data suggests that it does not generate a truncated protein but rather leads to loss of protein.

*2) Along the lines of 1, the authors should better explain the Eed western blot in [Figure 1A](#fig1){ref-type="fig"}. Why are there three bands for Eed? The largest band does not disappear upon EED CKO (it is marked by an \* in the figure). Could this be residual Eed? Can the authors use another antibody to rule out if it is a non-specific band, and not an alternate Eed isoform?*

The largest band marked by \"\*\" is a non-specific band. We made this more clear in the figure legend. The size of this band is larger than the size expected for full length EED. There are weak bands of remaining EED in the EED CKO that are likely due to signals from non-cardiomyocytes of P0 and P5 heart apex used for Western blot and RT-qPCR ([Figure 1---figure supplement 1](#fig1s1){ref-type="fig"}). PCR from genomic DNA of purified CMs ([Figure 1---figure supplement 2H](#fig1s2){ref-type="fig"}) confirmed nearly complete excision of floxed exons, and this was independently supported by RNA-seq ([Figure 1---figure supplement 2I](#fig1s2){ref-type="fig"}).

EED has multiple different isoforms: the Reinberg group, the Magnuson group, and our group showed that four EED isoforms exist and each varies during ESCs differentiation and heart development (Kuzmichev, 2005, PNAS; Montgomery, 2007, J. Mol. Biol.; He, 2012, Circ. Res.). These isoforms account for the multiple bands of EED on the western blot.
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